Literature DB >> 20414701

Inflammation-mediated promotion of invasion and metastasis.

Graziella Solinas1, Federica Marchesi, Cecilia Garlanda, Alberto Mantovani, Paola Allavena.   

Abstract

Inflammation has been suggested to represent the seventh hallmark of cancer. Myelomonocytic cells are a key component of cancer-related inflammation. Tumor-associated macrophages and their mediators affect key elements in the multistep process of invasion and metastasis, from interaction with the extracellular matrix to the construction of a pre-metastatic niche. Evidence indicating that inflammatory mediators affect genetic stability and cause persistent epigenetic alterations suggests that inflammatory components of the tumor microenvironment impacts on fundamental mechanisms responsible for the generation of metastatic variants. These results provide impetus for efforts aimed at translating cancer-related inflammation into diagnostic-prognostic markers and innovative therapeutic strategies.

Entities:  

Mesh:

Year:  2010        PMID: 20414701     DOI: 10.1007/s10555-010-9227-2

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  86 in total

1.  A Combination of Testosterone and White Blood Cell Count as a Predictive Factor of Overall Survival in Localized Prostate Cancer.

Authors:  Daniel Taussky; Denis Souliéres; Laurent Azoulay; Hui Yin; Houda Bahig; Jean-Paul Bahary; Guila Delouya
Journal:  Target Oncol       Date:  2017-10       Impact factor: 4.493

Review 2.  Cutaneous Notch signaling in health and disease.

Authors:  Craig Nowell; Freddy Radtke
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

3.  Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice.

Authors:  Jennifer L Owen; Michael F Criscitiello; Stephania Libreros; Ramon Garcia-Areas; Kathleen Guthrie; Marta Torroella-Kouri; Vijaya Iragavarapu-Charyulu
Journal:  Cell Immunol       Date:  2011-05-10       Impact factor: 4.868

Review 4.  Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.

Authors:  John M L Ebos; Robert S Kerbel
Journal:  Nat Rev Clin Oncol       Date:  2011-03-01       Impact factor: 66.675

5.  Recent advances in colorectal cancer research: the microenvironment impact.

Authors:  Anne-Laure Pin; François Houle; Jacques Huot
Journal:  Cancer Microenviron       Date:  2011-08

Review 6.  Targeting angiogenesis in lung cancer - Pitfalls in drug development.

Authors:  Wolfgang Hilbe; Christian Manegold; Andreas Pircher
Journal:  Transl Lung Cancer Res       Date:  2012-06

7.  Primary tumor regulates the pulmonary microenvironment in melanoma carcinoma model and facilitates lung metastasis.

Authors:  Mingyong Han; Jiying Xu; Yuli Bi; Man Jiang; Xiaoya Xu; Qi Liu; Jihui Jia
Journal:  J Cancer Res Clin Oncol       Date:  2012-08-19       Impact factor: 4.553

Review 8.  Oxidative DNA damage caused by inflammation may link to stress-induced non-targeted effects.

Authors:  Carl N Sprung; Alesia Ivashkevich; Helen B Forrester; Christophe E Redon; Alexandros Georgakilas; Olga A Martin
Journal:  Cancer Lett       Date:  2013-09-14       Impact factor: 8.679

Review 9.  Interleukins in glioblastoma pathophysiology: implications for therapy.

Authors:  Y T Yeung; K L McDonald; T Grewal; L Munoz
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

10.  microRNA-based cancer cell reprogramming technology.

Authors:  Shimpei Nishikawa; Hideshi Ishii; Naotsugu Haraguchi; Yoshihiro Kano; Takahito Fukusumi; Katsuya Ohta; Miyuki Ozaki; Dyah Laksmi Dewi; Daisuke Sakai; Taroh Satoh; Hiroaki Nagano; Yuichiro Doki; Masaki Mori
Journal:  Exp Ther Med       Date:  2012-04-23       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.